Pharmaceutical Working Group Annual Report 2021 Go back »

  • Published on:
  • Category:
  • by:
    Pharmaceutical Working Group / Forum
  • Keywords:


The Pharmaceutical Working Group represents 35 international pharmaceutical manufacturing companies operating in China. It engages in a constructive dialogue with all relevant government agencies at national, provincial and local levels and shares its expertise and international best practices with the Chinese authorities. In particular, the working group has established a sound communication channel with the Chinese medical authorities and regulators. The working group encourages government policies that support the creation of a sustainable environment that foster innovation and the healthy growth of the pharmaceutical industry as a whole, while improving patients’ access to affordable, innovative and high-quality medicines. The Pharmaceutical Working Group also offers recommendations based on experience accumulated during decades of healthcare reform in European countries that may further support the development of China’s healthcare system.

Related documents

Pharmaceutical Working Group Position Paper 2021/2022 - 制药工作组建议书 2021/2022

Pharmaceutical Working Group Annual Report 2020

Pharmaceutical Working Group Position Paper 2020/2021 - 制药工作组建议书2020/2021

Related EURObiz articles